Sight Sciences (SGHT) risk factors

Item 1A of every Sight Sciences, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.

Open SGHT in Gloom →

Sight Sciences' chart, financials and news, free in your browser.Open SGHT in Gloom →

FY2025 10-K risk factors
56 risks5 new3 dropped17 reworded
Sight Sciences added new risk disclosures regarding compliance with anti-boycott and anti-money laundering laws.
Filed Mar 04, 2026
FY2024 10-K risk factors
54 risks
Sight Sciences faces ongoing significant net losses with an accumulated deficit of $346.3 million as of December 31, 2024. The business relies heavily on the commercial success and adoption of its OMNI and TearCare products. Heavy reliance on debt financing, including a $65.0 million Hercules Loan Agreement, creates operational constraints.
Filed Mar 07, 2025